J Korean Thyroid Assoc.  2014 Nov;7(2):136-139. 10.11106/cet.2014.7.2.136.

Natural Course of Cytologically Diagnosed Benign Thyroid Nodules

• Kim EK

• KMID: 2095124
• DOI: http://doi.org/10.11106/cet.2014.7.2.136

Abstract

Thyroid nodules are very common and fine needle aspiration is an accurate and cost effective diagnostic tool for differentiating malignant and benign thyroid nodules. Benign diagnosis on cytology is accurate and reliable, however, follow up sonography or fine needle aspiration is recommended to rule out malignancy. Until now, there are few studies regarding natural course of cytologically diagnosed benign thyroid nodules. In this review, malignant risk and long-term follow up data of cytologically diagnosed benign thyroid nodules is discussed.

Keyword

Thyroid nodule; Ultrasonography; Fine needle aspiration; Follow-up studies

MeSH Terms

Biopsy, Fine-Needle
Diagnosis
Follow-Up Studies
Thyroid Nodule*
Ultrasonography

Reference

References

1. Mazzaferri EL, de los Santos ET, Rofagha-Keyhani S. Solitary thyroid nodule: diagnosis and management. Med Clin North Am. 1988; 72(5):1177–211.

2. Layfield LJ, Cibas ES, Gharib H, Mandel SJ. Thyroid aspiration cytology: current status. CA Cancer J Clin. 2009; 59(2):99–110.

3. Castro MR, Gharib H. Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls. Endocr Pract. 2003; 9(2):128–36.

4. Cai XJ, Valiyaparambath N, Nixon P, Waghorn A, Giles T, Helliwell T. Ultrasound-guided fine needle aspiration cytology in the diagnosis and management of thyroid nodules. Cytopathology. 2006; 17(5):251–6.

5. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL. et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19(11):1167–214.

6. Powsner SM, Costa J, Homer RJ. Clinicians are from Mars and pathologists are from Venus. Arch Pathol Lab Med. 2000; 124(7):1040–6.

7. Moon HJ, Kwak JY, Kim EK. A glance at the Bethesda system for reporting thyroid cytopathology. J Korean Soc Ultrasound Med. 2011; 30(1):1–6.

8. Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009; 132(5):658–65.

9. Renshaw AA. Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves. Am J Clin Pathol. 2001; 116(4):477–82.

10. Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007; 111(5):306–15.

11. Jo VY, Stelow EB, Dustin SM, Hanley KZ. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2010; 134(3):450–6.

12. Theoharis CG, Schofield KM, Hammers L, Udelsman R, Chhieng DC. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid. 2009; 19(11):1215–23.

13. Kwak JY, Kim EK, Kim HJ, Kim MJ, Son EJ, Moon HJ. How to combine ultrasound and cytological information in decision making about thyroid nodules. Eur Radiol. 2009; 19(8):1923–31.

14. Gabalec F, Cap J, Ryska A, Vasatko T, Ceeova V. Benign fine-needle aspiration cytology of thyroid nodule: to repeat or not to repeat? Eur J Endocrinol. 2009; 161(6):933–7.

15. Kwak JY, Koo H, Youk JH, Kim MJ, Moon HJ, Son EJ. et al. Value of US correlation of a thyroid nodule with initially benign cytologic results. Radiology. 2010; 254(1):292–300.

16. Choi YJ, Jung I, Min SJ, Kim HJ, Kim JH, Kim S. et al. Thyroid nodule with benign cytology: is clinical follow-up enough? PLoS One. 2013; 8(5):e63834.

17. Ha EJ, Baek JH, Lee JH, Song DE, Kim JK, Shong YK. et al. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy. Thyroid. 2013; 23(6):703–8.

18. McCoy KL, Jabbour N, Ogilvie JB, Ohori NP, Carty SE, Yim JH. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery. 2007; 142(6):837–44. discussion 44 e1-3.

19. Wharry LI, McCoy KL, Stang MT, Armstrong MJ, LeBeau SO, Tublin ME. et al. Thyroid nodules (>/=4 cm): can ultrasound and cytology reliably exclude cancer? World J Surg. 2014; 38(3):614–21.

20. Porterfield JR Jr, Grant CS, Dean DS, Thompson GB, Farley DR, Richards ML. et al. Reliability of benign fine needle aspiration cytology of large thyroid nodules. Surgery. 2008; 144(6):963–8. discussion 8-9.

21. Kuma K, Matsuzuka F, Yokozawa T, Miyauchi A, Sugawara M. Fate of untreated benign thyroid nodules: results of long-term follow-up. World J Surg. 1994; 18(4):495–8. discussion 9.

22. Alexander EK, Hurwitz S, Heering JP, Benson CB, Frates MC, Doubilet PM. et al. Natural history of benign solid and cystic thyroid nodules. Ann Intern Med. 2003; 138(4):315–8.

23. Kim SY, Han KH, Moon HJ, Kwak JY, Chung WY, Kim EK. Thyroid nodules with benign findings at cytologic examination: results of long-term follow-up with US. Radiology. 2014; 271(1):272–81.

24. Lim DJ, Kim JY, Baek KH, Kim MK, Park WC, Lee JM. et al. Natural course of cytologically benign thyroid nodules: observation of ultrasonographic changes. Endocrinol Metab (Seoul). 2013; 28(2):110–8.

25. Lee S, Skelton TS, Zheng F, Schwartz KA, Perrier ND, Lee JE. et al. The biopsy-proven benign thyroid nodule: is long-term follow-up necessary? J Am Coll Surg. 2013; 217(1):81–8. discussion 8-9.